Literature DB >> 32378032

Serious Mental Illness and Smoking Cessation Treatment Utilization: the Role of Healthcare Providers.

Patrick J Hammett1,2, Brent C Taylor3,4, Harry A Lando5, Rachel Widome5, Darin J Erickson5, Steven S Fu3,4.   

Abstract

Healthcare provider barriers to cessation resources may be undercutting quit rates for smokers with serious mental illness (SMI). The study aim was to examine how providers influence cessation treatment utilization among smokers with SMI. Data were taken from a trial conducted among smokers in Minnesota Health Care Programs. The sample was split into groups of participants with SMI (n = 939) and without SMI (n = 1382). Analyses assessed whether the association between SMI and treatment utilization was mediated by healthcare provider-delivered treatment advice and healthcare provider bias. Results revealed higher rates of treatment utilization among smokers with SMI than those without SMI (45.9% vs 31.7%, p < 0.001); treatment advice and provider bias did not mediate this association. Subsequent individual regression analyses revealed positive associations between treatment advice and treatment utilization (β 0.21-0.25, p < 0.05), independent of SMI status. Strategies to increase low-income smokers' contacts with providers may reduce treatment utilization barriers among these smokers.

Entities:  

Mesh:

Year:  2021        PMID: 32378032      PMCID: PMC7644603          DOI: 10.1007/s11414-020-09707-3

Source DB:  PubMed          Journal:  J Behav Health Serv Res        ISSN: 1094-3412            Impact factor:   1.505


  26 in total

1.  Identifiability and exchangeability for direct and indirect effects.

Authors:  J M Robins; S Greenland
Journal:  Epidemiology       Date:  1992-03       Impact factor: 4.822

2.  'Diagnostic overshadowing': worse physical health care for people with mental illness.

Authors:  Simon Jones; Louise Howard; Graham Thornicroft
Journal:  Acta Psychiatr Scand       Date:  2008-09       Impact factor: 6.392

3.  Healthcare report cards and tobacco measures.

Authors:  R M Davis
Journal:  Tob Control       Date:  1997       Impact factor: 7.552

4.  Race, unemployment rate, and chronic mental illness: a 15-year trend analysis.

Authors:  Celia C Lo; Tyrone C Cheng
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-21       Impact factor: 4.328

5.  Factors influencing implementation of smoking cessation treatment within community mental health centers.

Authors:  Clayton H Brown; Deborah Medoff; Faith B Dickerson; Li Juan Fang; Alicia Lucksted; Richard W Goldberg; Julie Kreyenbuhl; Seth Himelhoch; Lisa B Dixon
Journal:  J Dual Diagn       Date:  2015

6.  Bupropion and cognitive-behavioral treatment for depression in smoking cessation.

Authors:  Richard A Brown; Raymond Niaura; Elizabeth E Lloyd-Richardson; David R Strong; Christopher W Kahler; Ana M Abrantes; David Abrams; Ivan W Miller
Journal:  Nicotine Tob Res       Date:  2007-07       Impact factor: 4.244

7.  Proactive Tobacco Treatment for Smokers Using Veterans Administration Mental Health Clinics.

Authors:  Erin S Rogers; Steven S Fu; Paul Krebs; Siamak Noorbaloochi; Sean M Nugent; Amy Gravely; Scott E Sherman
Journal:  Am J Prev Med       Date:  2018-03-15       Impact factor: 5.043

8.  Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.

Authors:  John A Stapleton; Lucy Watson; Lucy I Spirling; Robert Smith; Andrea Milbrandt; Marina Ratcliffe; Gay Sutherland
Journal:  Addiction       Date:  2007-11-19       Impact factor: 6.526

9.  Smoking, mental illness and socioeconomic disadvantage: analysis of the Australian National Survey of Mental Health and Wellbeing.

Authors:  David Lawrence; Jennifer Hafekost; Philip Hull; Francis Mitrou; Stephen R Zubrick
Journal:  BMC Public Health       Date:  2013-05-11       Impact factor: 3.295

10.  Vital signs: current cigarette smoking among adults aged ≥18 years with mental illness - United States, 2009-2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-02-08       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.